Journals / Çocuk Dergisi / 2011 / Cilt: 11 - Sayı: 4

Idiopathic Short Stature

İdiyopatik Boy Kısalığı

Pages
147–150
Publication Date
2011-10-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Following appropriate evaluations, children with ISS can be treated with a multifaceted treatment pro- tocol and satisfactory results can be achieved

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Idiopathic short stature ISS refers to the condition where the height is below-2 standard deviation score SDS wit- hout any underlying disease.
📊
Key Findings & Data:It may be divided in two gro- ups as familial short stature and non-familial short stature.
💡
Conclusion & Impact:Following appropriate evaluations, children with ISS can be treated with a multifaceted treatment pro- tocol and satisfactory results can be achieved
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İdiyopatik boy kısalığı · ailevi boy kısalığı · ailevi olmayan boy kısalığı

Abstract

Idiopathic short stature ISS refers to the condition where the height is below-2 standard deviation score SDS wit- hout any underlying disease. It may be divided in two gro- ups as familial short stature and non-familial short stature. The pathophysiology of ISS is multifaceted and very hete- rogeneous. Following appropriate evaluations, children with ISS can be treated with a multifaceted treatment pro- tocol and satisfactory results can be achieved

Özet

İdiyopatik boy kısalığı İBK , boyun - 2 standart deviasyon skorunun SDS altında olması ve altta yatan herhangi bir hastalığın olmamasıdır. Ailevi boy kısalığı ve ailevi olma- yan boy kısalığı olarak iki gruba ayrılır. İBK patofizyoloji- si çok geniş ve heterojendir. Boy kısalığı nedenleri açısın- dan uygun değerlendirmeler yapılıp, İBK tanısı ile takip edilmeye başlanan çocuklar için çok yönlü tedavi protokol- leri denenmekte ve olumlu sonuçlar alınabilmektedir

🔖

Cite This Article

DARENDELİLER, F., AYDIN, B. K., BAŞ, F. (2011). Idiopathic Short Stature. Çocuk Dergisi, Cilt: 11 - Sayı: 4, 147–150. https://ajindex.com/articles/247033

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ranke MB. Towards a consensus on the definition of idiopathic short stature. Horm Res 1996
  2. 45(Suppl. 2):64-6. http://dx.doi.org/10.1159/000184851 PMid:8805048 2. Bryant J, Baxter L, Cave C, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev 2007
  3. CD004440. PMid:17636758 3. Wit JM, Ranke MB, Kelnar CJH. ESPE classification of paediatric endocrine diagnosis. Horm Res 2007
  4. 68(Suppl. 2):1-120. 4. Pedicelli S, Peschiaroli E, Violi E, Cianfarani S. Controversies in the definition and treatment of idiopathic short stature. J Clin Res Ped Endo 2009
  5. 1(3):105-15. 5. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 2008
  6. http://dx.doi.org/10.1016/j.ghir.2007.11.004 6. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, et al. Clinical features and endocrine status in patients with growth hormone insensitivity. J Clin Endocrinol Metab 1993
  7. http://dx.doi.org/10.1210/jc.77.6.1465 7. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, et al. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin İnvest 2006
  8. http://dx.doi.org/10.1172/JCI25303 PMid:16511605 PMCid:1386106 8. Besson A, Salemi S, Deladoe¨y J, Vuissoz JM, Eble´ A, Bidlingmaier M, et al. Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab 2005
  9. 90(5):2493-9. http://dx.doi.org/10.1210/jc.2004-1838 9. Tiulpakov A, Rubtsov P, Dedov I, Peterkova V, Bezlepkina O, Chrousos GP, et al. A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling. J Clin Endocrinol Metab 2005
  10. 90(1):542-7. http://dx.doi.org/10.1210/jc.2003-2133 10. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003
  11. http://dx.doi.org/10.1056/NEJMoa022926 PMid:13679528 11. Woods KA, Camacho-Hübner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin like growth factor 1 gene. N Engl J Med 1996
  12. http://dx.doi.org/10.1056/NEJM199610313351805 PMid:8857020 12. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, et al. IGF-I receptor mutations resulti